Stay updated with breaking news from Cipla india. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A 2015 study showed that only 10 percent of drugs on the Uganda pharmaceutical market are manufactured locally. The vast bulk of the medicines are from India and China ....
The takeovers, which bear a collective value of more than $100 million, have signalled a departure from dull deal-making activity pegged to local manufacturing. ....
Cipla Quality Chemicals (QCIL) has sold its majority stake or 51.18 pc of the total company’s ordinary shares to a Mauritius-based investment firm for $25 million (about Shs93.7 b,) after the. ....
Date Time Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India – one of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients. Conducted in 12 public and private hospitals across India, the COVID India Tocilizumab (COVINTOC) phase 3 randomised controlled trial aimed to investigate whether tocilizumab could prevent disease progression and mortality in hospitalised patients with moderate to severe COVID-19. ....